Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
SCY1-like 1-binding protein 1
(
SCYL1BP1
) is a newly identified
transcriptional activator
domain containing a protein with many unknown biological functions. Recently emerging evidence has revealed that it is a novel regulator of the p53 pathway, which is required for neurite outgrowth and regeneration. Here we present evidence that
SCYL1BP1
inhibits nerve growth factor-mediated neurite outgrowth in PC12 cells and affects morphogenesis of primary cortical neurons by strongly decreasing the p53 protein level in vitro, all of which depends on
SCYL1BP1
's
transcriptional activator
domain. Exogenous p53 rescues neurite outgrowth and neuronal morphogenesis defects caused by
SCYL1BP1
. Furthermore,
SCYL1BP1
can directly induce Mdm2 transcription, whereas inhibiting the function of Mdm2 by specific small interfering RNAs results in partial rescue of neurite outgrowth and neuronal morphogenesis defects induced by
SCYL1BP1
. In vivo experiments show that
SCYL1BP1
can also depress axonal regeneration, whereas inhibiting the function of
SCYL1BP1
by specific short hairpin RNA enhances it. Taken together, these data strongly suggested that
SCYL1BP1
is a novel
transcriptional activator
in neurite outgrowth by directly modulating the Mdm2/p53-dependent pathway, which might play an important role in CNS development and axonal regeneration after injury.
...
PMID:SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway. 2305 35
SCY1-like 1-binding protein 1
(
SCYL1BP1
) is a newly identified
transcriptional activator
domain containing protein with many unknown biological functions. Recently emerging evidence has revealed that it is a novel regulator of the p53 pathway, which is very important for the development of human cancer. However, the effects of
SCYL1BP1
on human lung squamous carcinoma cell biological behavior remain poorly understood. In this study, we present evidence that
SCYL1BP1
can promote the degradation of MDM2 protein and further inhibit the G1/S transition of lung squamous carcinoma cell lines. Functional assays found that reintroduction of
SCYL1BP1
into lung squamous carcinoma cell lines significantly inhibited cell proliferation, migration, invasion and tumor formation in nude mice, suggesting strong tumor suppressive function of
SCYL1BP1
in lung squamous carcinoma. Taken together, our data suggest that the interaction of
SCYL1BP1
/MDM2 could accelerate MDM2 degradation, and may function as an important tumor suppressor in lung squamous carcinomas.
...
PMID:SCYL1BP1 has tumor-suppressive functions in human lung squamous carcinoma cells by regulating degradation of MDM2. 2522 60